Statistical analysis of time to event outcomes in clinical trials
Dr J Bartlett
16 December 2018
Overview. Many clinical trials of new drugs or treatments involve recruiting patients into the trial, randomising them to one of the treatments under study, and measuring how long until each patient experiences an adverse event of interest, such as cancer progression, heart attack, or death.
Encouraging retention in clinical trials (ERIC)
Dr S Cotterill, Dr S Peters, Prof A Vail
Applications accepted all year round
Clinical trials often require longer term follow-up measures, collected months or years after completion of the intervention. Such trials struggle to retain participants, leading to.